Michael Gross

Michael is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. Michael serves as a board director for Beringea portfolio companies Molecular Imaging, Delphinus Medical Technologies, InTouch Health, Intervention Insights, Xanitos, Freeosk, and Fiber By-Products, and is a board observer for MedVantx. Previous portfolio companies include Pioneer Surgical Technology (acquired by RTI Biologics), Relume Technology (acquired by Revolution Lighting), and Ecosynthetix (TSX: ECO). Prior to joining Beringea, Michael was a vice president of investment banking with P&M Corporate Finance (PMCF). While at PMCF, Michael led M&A transactions and capital raises for companies in the life sciences, health care and outsourced business services sectors. Before working at PMCF, Michael worked in the investment banking group at Stout Risius Ross, Inc. Michael is a CFA charterholder and earned a B.A. in Finance from Michigan State University.